Oncology News

In utero exposure to dicyclomine may be associated with increased risk for adult-onset colorectal cancer, results of a retrospective study suggest.

As the effective date of UnitedHealthcare’s prior authorization policy for gastroenterology endoscopy services quickly approaches, the ACG, AGA and ASGE alongside 175 allied organizations have rallied to stop its implementation.

An artificial intelligence tool developed at Harvard Medical School and National Cheng Kung University in Taiwan correctly predicted the aggressiveness of colorectal cancer.

Compared with reoffering colonoscopy and fecal immunochemical test alone, offering a blood test as a secondary option resulted in a nearly twofold increase in colorectal cancer screening in veterans who had declined first-line screening.

Minimally invasive surgery appeared safe and just as effective as open surgery for patients with resectable pancreatic cancer, according to results of the DIPLOMA trial scheduled for presentation at ASCO Annual Meeting.

Racial disparities in gastrointestinal cancer mortality decreased in states that expanded Medicaid coverage under the Affordable Care Act while staying the same or increasing in states that did not, study results showed.

Patients with all stages of Barrett’s esophagus had similar cancer worry, highlighting the need for improved health-related quality of life through education, reassurance and follow-up care, according to data in BMJ Open Gastroenterology.

CHICAGO — A cell-free DNA blood-based test displayed 83% sensitivity for colorectal cancer detection and 90% specificity in an average-risk population, similar to the performance of current noninvasive screening options.

In this episode of Meeting Mic, we bring you Healio’s top headlines from DDW 2023.

CHICAGO — Colorectal cancer screening rates at federally qualified health centers were significantly higher in states that expanded Medicaid under the Affordable Care Act vs. states that did not, according to data at Digestive Disease Week.